Effects of Telmisartan on a Murine Model of Non-Alcoholic Steatohepatitis (NASH) and NASH-Related Hepatocellular Carcinoma

被引：0
|
作者：
Shibazaki, Yuichiro
Fujii, Masato
Wakamatsu, Kyoko
Hashiguchi, Taishi
Honma, Taihei
Furuuchi, Miho
Sakurai, Maki
Nishimura, Nobuyo
Yoneyama, Hiroyuki
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S543 / S543
页数：1
相关论文
共 50 条
  • [1] A Novel Murine Model Recapitulates the Pathogenesis of Human Non-Alcoholic Steatohepatitis (NASH) and NASH-Related Hepatocellular Carcinoma
    Fujii, Masato
    Shibazaki, Yuichiro
    Wakamatsu, Kyoko
    Honma, Taihei
    Hashiguchi, Taishi
    Sakurai, Maki
    Furuuchi, Miho
    Nishimura, Nobuyo
    Suzuki, Kenji
    Ichida, Takafumi
    Yoneyama, Hiroyuki
    GASTROENTEROLOGY, 2012, 142 (05) : S546 - S546
  • [2] A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
    Younossi, Zobair M.
    Page, Sandra
    Rafiq, Nila
    Birerdinc, Aybike
    Stepanova, Maria
    Hossain, Noreen
    Afendy, Arian
    Younoszai, Zahra
    Goodman, Zachary
    Baranova, Ancha
    OBESITY SURGERY, 2011, 21 (04) : 431 - 439
  • [3] A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
    Zobair M. Younossi
    Sandra Page
    Nila Rafiq
    Aybike Birerdinc
    Maria Stepanova
    Noreen Hossain
    Arian Afendy
    Zahra Younoszai
    Zachary Goodman
    Ancha Baranova
    Obesity Surgery, 2011, 21 : 431 - 439
  • [4] Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma
    Cuadrado, A
    Orive, A
    García-Suárez, C
    Domínguez, A
    Fernández-Escalante, JC
    Crespo, J
    Pons-Romero, F
    OBESITY SURGERY, 2005, 15 (03) : 442 - 446
  • [5] Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma
    Antonio Cuadrado
    Aitor Orive
    Covadonga García-Suárez
    Agustín Domínguez
    Jose Carlos Fernández-Escalante
    Javier Crespo
    Fernando Pons-Romero
    Obesity Surgery, 2005, 15 : 442 - 446
  • [6] Screening of non-alcoholic steatohepatitis (NASH)-related datasets and identification of NASH-related genes
    Liu, Ming-Jiang
    Jin, Hu
    Chen, Yu-Bing
    Yu, Jing-Jing
    Guo, Zhen-Ya
    He, Song-Qing
    Zeng, Yong-Lian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2021, 14 (05): : 567 - 581
  • [7] MRI presentation of hepatocellular carcinoma in non-alcoholic steatohepatitis (NASH)
    Al-Sharhan, Fatima
    Dohan, Anthony
    Barat, Maxime
    Feddal, Adlane
    Terris, Benoit
    Pol, Stanislas
    Mallet, Vincent
    Soyer, Philippe
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 119
  • [8] A NOVEL SERUM-BASED BIOMARKER PANEL FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND NASH-RELATED FIBROSIS
    Younossi, Zobair M.
    Rafiq, Nila
    Page, Sandra
    Stepanova, Maria
    Hossain, Noreen
    Birerdinc, Aybike
    Younoszai, Zahra
    Goodman, Zachary D.
    Baranova, Ancha
    HEPATOLOGY, 2009, 50 (04) : 782A - 782A
  • [9] Non-alcoholic fatty liver disease (NAFLD) progression to non-alcoholic steatohepatitis (NASH) and NASH-related hepatocellular carcinoma (HCC) evolves following a differential activation of endoplasmic reticulum stress responses
    Finnemore, Alexander
    Maria Herranz, Jose
    Barace, Sergio
    Infante, Stefany
    Avila, Matias A.
    Garcia-Porrero, Guillermo
    Arcelus, Sara
    Santamaria, Eva
    Argemi, Josepmaria
    JOURNAL OF HEPATOLOGY, 2022, 77 : S697 - S697
  • [10] LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) COMPARED TO NON-NASH PATIENTS
    Sadler, Erin
    Mehta, Neil
    Bhat, Mamatha
    Ghanekar, Anand
    Greig, Paul
    Grant, David
    Yao, Francis
    Sapisochin, Gonzalo
    TRANSPLANT INTERNATIONAL, 2017, 30 : 93 - 93
12345